和邦生物(603077.SH)：前三季度净利润9310.85万元，同比下降57.93%

Core Viewpoint - Hebang Biotechnology (603077.SH) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters reached 5.927 billion yuan, representing a year-on-year decrease of 13.02% [1] - The net profit attributable to shareholders was 93.1085 million yuan, down 57.93% year-on-year [1] - The basic earnings per share were 0.0117 yuan [1]